person · Reporting owner

Lipschultz Tyler

Disclosed activity across 2 companies

Tapewire entity: 22203
SEC CIK: 0001509284

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Xtant Medical Holdings, Inc.XTNT · Entity 7196	Director	August 15, 2026	August 18, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Xtant Medical Holdings, Inc.

Report date August 15, 2026 · Filed August 18, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	373,745	Reported balance After 2026-08-15 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2026-08-15 · Grant · Acquired 215,517 · Balance 373,745 F1: These shares are subject to a restricted stock unit (RSU) award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan and will vest on August 15, 2027, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2: Includes 373,745 shares issuable upon vesting of RSUs granted under the Xtant Medial Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of Xtant through the respective vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: These shares are subject to a restricted stock unit (RSU) award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan and will vest on August 15, 2027, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F2: Includes 373,745 shares issuable upon vesting of RSUs granted under the Xtant Medial Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of Xtant through the respective vesting date.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

SeaSpine Holdings Corp

Report date January 05, 2023 · Filed January 10, 2023

Section 16 reporting ended · disclosed 2023-01-10. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2023-01-05 transaction · row 1 1 source row Row 1 · 2023-01-05 · Disposition to issuer · Disposed 131,284 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 54,653 Orthofix MedicalInc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2023-01-05 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2023-01-05 · Disposition to issuer · Disposed 12,970 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F4: These restricted stock units were assumed by Orthofix in the merger and replaced by 5,399 Orthofix restricted stock units. F3: The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2023-01-05 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2023-01-05 · Disposition to issuer · Disposed 33,977 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F6: These restricted stock units were assumed by Orthofix in the merger and replaced by 14,144 Orthofix restricted stock units. F5: The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025.
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.68 · Expires 2025-08-01	Direct	Reported balance After 2023-01-05 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2023-01-05 · Disposition to issuer · Disposed 60,000 · Balance 0 F8: This option was assumed by Orthofix in the merger and replaced with an option to purchase 24,978 shares of Orthofix at a price of $37.67 per share. F7: The option vests as to 25% of the underlying shares on August 1, 2016 and the remaining 75% vests in twelve substantially equal quarterly installments thereafter.
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.19 · Expires 2024-01-27	Direct	Reported balance After 2023-01-05 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2023-01-05 · Disposition to issuer · Disposed 64,599 · Balance 0 F10: This option was assumed by Orthofix in the merger and replaced with an option to purchase 26,892 shares of Orthofix at a price of $34.09 per share. F9: The option vests as to 12.5% of the underlying shares on August 1, 2016, 6.25% on September 30, 2016 and the remaining 81.25% vests in thirteen substantially equal quarterly installments thereafter.
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.24 · Expires 2027-01-01	Direct	Reported balance After 2023-01-05 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2023-01-05 · Disposition to issuer · Disposed 35,636 · Balance 0 F12: This option was assumed by Orthofix in the merger and replaced with an option to purchase 14,835 shares of Orthofix at a price of $43.82 per share. F11: The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.01 · Expires 2028-01-01	Direct	Reported balance After 2023-01-05 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2023-01-05 · Disposition to issuer · Disposed 27,873 · Balance 0 F14: This option was assumed by Orthofix in the merger and replaced with an option to purchase 11,603 shares of Orthofix at a price of $28.85 per share. F13: The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.93 · Expires 2028-04-23	Direct	Reported balance After 2023-01-05 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2023-01-05 · Disposition to issuer · Disposed 6,089 · Balance 0 F16: This option was assumed by Orthofix in the merger and replaced with an option to purchase 2,534 shares of Orthofix at a price of $23.86 per share. F15: The option fully vested and became exercisable on June 21, 2020.
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.86 · Expires 2029-01-28	Direct	Reported balance After 2023-01-05 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2023-01-05 · Disposition to issuer · Disposed 16,196 · Balance 0 F18: This option was assumed by Orthofix in the merger and replaced with an option to purchase 6,742 shares of Orthofix at a price of $40.50 per share. F17: The option vests as to 25% of the underlying shares on January 28, 2022 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.00 · Expires 2030-02-28	Direct	Reported balance After 2023-01-05 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2023-01-05 · Disposition to issuer · Disposed 21,236 · Balance 0 F20: This option was assumed by Orthofix in the merger and replaced with an option to purchase 8,840 shares of Orthofix at a price of $36.04 per share. F19: The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter.

Filing footnotes · ownership attribution and instrument terms

F1: Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 54,653 Orthofix MedicalInc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger.

F2: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F3: The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024.

F4: These restricted stock units were assumed by Orthofix in the merger and replaced by 5,399 Orthofix restricted stock units.

F5: The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025.

F6: These restricted stock units were assumed by Orthofix in the merger and replaced by 14,144 Orthofix restricted stock units.

F7: The option vests as to 25% of the underlying shares on August 1, 2016 and the remaining 75% vests in twelve substantially equal quarterly installments thereafter.

F8: This option was assumed by Orthofix in the merger and replaced with an option to purchase 24,978 shares of Orthofix at a price of $37.67 per share.

F9: The option vests as to 12.5% of the underlying shares on August 1, 2016, 6.25% on September 30, 2016 and the remaining 81.25% vests in thirteen substantially equal quarterly installments thereafter.

F10: This option was assumed by Orthofix in the merger and replaced with an option to purchase 26,892 shares of Orthofix at a price of $34.09 per share.

F11: The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% in twelve substantially equal quarterly installments thereafter.

F12: This option was assumed by Orthofix in the merger and replaced with an option to purchase 14,835 shares of Orthofix at a price of $43.82 per share.

F13: The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter.

F14: This option was assumed by Orthofix in the merger and replaced with an option to purchase 11,603 shares of Orthofix at a price of $28.85 per share.

F15: The option fully vested and became exercisable on June 21, 2020.

F16: This option was assumed by Orthofix in the merger and replaced with an option to purchase 2,534 shares of Orthofix at a price of $23.86 per share.

F17: The option vests as to 25% of the underlying shares on January 28, 2022 and the remaining 75% in twelve substantially equal quarterly installments thereafter.

F18: This option was assumed by Orthofix in the merger and replaced with an option to purchase 6,742 shares of Orthofix at a price of $40.50 per share.

F19: The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter.

F20: This option was assumed by Orthofix in the merger and replaced with an option to purchase 8,840 shares of Orthofix at a price of $36.04 per share.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
August 15, 2026 Filed Aug 18, 2026 22:35 UTC	Xtant Medical Holdings, Inc. XTNT · Entity 7196	GrantCommon Stock	215,517	$0.00	$0.00	Disclosure SEC source: 0001509284-26-000001 · primary_doc.xml · nonDerivative · entry 1 Lipschultz Tyler · CIK 0001509284 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 373,745 F1 · shares: These shares are subject to a restricted stock unit (RSU) award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan and will vest on August 15, 2027, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 373,745 shares issuable upon vesting of RSUs granted under the Xtant Medial Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of Xtant through the respective vesting date. Read SEC document
November 15, 2025 Filed Nov 18, 2025 22:06 UTC	Xtant Medical Holdings, Inc. XTNT · Entity 7196	GrantCommon Stock	158,228	$0.00	$0.00	Disclosure SEC source: 0001509284-25-000004 · primary_doc.xml · nonDerivative · entry 1 Lipschultz Tyler · CIK 0001509284 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,228 F1 · shares: These shares are subject to a deferred stock unit (DSU) award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan and will vest on November 15, 2026, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date. The settlement of the vested shares underlying the DSU award has been deferred and will occur at a later date pursuant to the terms of the DSU award agreement. Each DSU represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 158,228 shares issuable upon settlement of deferred stock units granted under the Xtant Medial Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date. Read SEC document
January 05, 2023 Filed Jan 10, 2023 00:18 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative	21,236	Not disclosed Strike: $15.00	Not disclosed	Disclosure SEC source: 0001637761-23-000036 · wf-form4_167330987023732.xml · derivative · entry 10 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,236 shares Expires 2030-02-28 F20 · price: This option was assumed by Orthofix in the merger and replaced with an option to purchase 8,840 shares of Orthofix at a price of $36.04 per share. F19 · derivative.exercise_date: The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter. Read SEC document
January 05, 2023 Filed Jan 10, 2023 00:18 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative	16,196	Not disclosed Strike: $16.86	Not disclosed	Disclosure SEC source: 0001637761-23-000036 · wf-form4_167330987023732.xml · derivative · entry 9 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,196 shares Expires 2029-01-28 F18 · price: This option was assumed by Orthofix in the merger and replaced with an option to purchase 6,742 shares of Orthofix at a price of $40.50 per share. F17 · derivative.exercise_date: The option vests as to 25% of the underlying shares on January 28, 2022 and the remaining 75% in twelve substantially equal quarterly installments thereafter. Read SEC document
January 05, 2023 Filed Jan 10, 2023 00:18 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative	6,089	Not disclosed Strike: $9.93	Not disclosed	Disclosure SEC source: 0001637761-23-000036 · wf-form4_167330987023732.xml · derivative · entry 8 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,089 shares Expires 2028-04-23 F16 · price: This option was assumed by Orthofix in the merger and replaced with an option to purchase 2,534 shares of Orthofix at a price of $23.86 per share. F15 · derivative.exercise_date: The option fully vested and became exercisable on June 21, 2020. Read SEC document
January 05, 2023 Filed Jan 10, 2023 00:18 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative	27,873	Not disclosed Strike: $12.01	Not disclosed	Disclosure SEC source: 0001637761-23-000036 · wf-form4_167330987023732.xml · derivative · entry 7 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,873 shares Expires 2028-01-01 F14 · price: This option was assumed by Orthofix in the merger and replaced with an option to purchase 11,603 shares of Orthofix at a price of $28.85 per share. F13 · derivative.exercise_date: The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter. Read SEC document
January 05, 2023 Filed Jan 10, 2023 00:18 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative	35,636	Not disclosed Strike: $18.24	Not disclosed	Disclosure SEC source: 0001637761-23-000036 · wf-form4_167330987023732.xml · derivative · entry 6 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,636 shares Expires 2027-01-01 F12 · price: This option was assumed by Orthofix in the merger and replaced with an option to purchase 14,835 shares of Orthofix at a price of $43.82 per share. F11 · derivative.exercise_date: The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% in twelve substantially equal quarterly installments thereafter. Read SEC document
January 05, 2023 Filed Jan 10, 2023 00:18 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative	64,599	Not disclosed Strike: $14.19	Not disclosed	Disclosure SEC source: 0001637761-23-000036 · wf-form4_167330987023732.xml · derivative · entry 5 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 64,599 shares Expires 2024-01-27 F10 · price: This option was assumed by Orthofix in the merger and replaced with an option to purchase 26,892 shares of Orthofix at a price of $34.09 per share. F9 · derivative.exercise_date: The option vests as to 12.5% of the underlying shares on August 1, 2016, 6.25% on September 30, 2016 and the remaining 81.25% vests in thirteen substantially equal quarterly installments thereafter. Read SEC document
January 05, 2023 Filed Jan 10, 2023 00:18 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative	60,000	Not disclosed Strike: $15.68	Not disclosed	Disclosure SEC source: 0001637761-23-000036 · wf-form4_167330987023732.xml · derivative · entry 4 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,000 shares Expires 2025-08-01 F8 · price: This option was assumed by Orthofix in the merger and replaced with an option to purchase 24,978 shares of Orthofix at a price of $37.67 per share. F7 · derivative.exercise_date: The option vests as to 25% of the underlying shares on August 1, 2016 and the remaining 75% vests in twelve substantially equal quarterly installments thereafter. Read SEC document
January 05, 2023 Filed Jan 10, 2023 00:18 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Disposition to issuerRestricted Stock Units · Derivative	33,977	Not disclosed Strike: $0.00	Not disclosed	Disclosure SEC source: 0001637761-23-000036 · wf-form4_167330987023732.xml · derivative · entry 3 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,977 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F6 · price: These restricted stock units were assumed by Orthofix in the merger and replaced by 14,144 Orthofix restricted stock units. F5 · derivative.exercise_date: The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025. F5 · derivative.expiration_date: The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025. Read SEC document
January 05, 2023 Filed Jan 10, 2023 00:18 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Disposition to issuerRestricted Stock Units · Derivative	12,970	Not disclosed	Not disclosed	Disclosure SEC source: 0001637761-23-000036 · wf-form4_167330987023732.xml · derivative · entry 2 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,970 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F4 · price: These restricted stock units were assumed by Orthofix in the merger and replaced by 5,399 Orthofix restricted stock units. F3 · derivative.exercise_date: The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024. F3 · derivative.expiration_date: The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024. Read SEC document
January 05, 2023 Filed Jan 10, 2023 00:18 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Disposition to issuerCommon Stock	131,284	Not disclosed	Not disclosed	Disclosure SEC source: 0001637761-23-000036 · wf-form4_167330987023732.xml · nonDerivative · entry 1 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 54,653 Orthofix MedicalInc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger. Read SEC document
January 01, 2023 Filed Jan 3, 2023 22:24 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionRestricted Stock Units · Derivative	8,362	$0.00	$0.00	Disclosure SEC source: 0001637761-23-000013 · wf-form4_167278467472357.xml · derivative · entry 3 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,362 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The reporting person was granted 25,086 restricted stock units on January 1, 2020, which vested in three equal installments on each of January 1, 2021, 2022 and 2023. F3 · derivative.expiration_date: The reporting person was granted 25,086 restricted stock units on January 1, 2020, which vested in three equal installments on each of January 1, 2021, 2022 and 2023. Read SEC document
January 01, 2023 Filed Jan 3, 2023 22:24 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Tax withholdingCommon Stock	3,411	$8.35	$28,481.85	Disclosure SEC source: 0001637761-23-000013 · wf-form4_167278467472357.xml · nonDerivative · entry 2 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,284 F2 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units that occurred on January 1, 2023. No shares were sold in connection with this transaction. Read SEC document
January 01, 2023 Filed Jan 3, 2023 22:24 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionCommon Stock	8,362	Not disclosed	Not disclosed	Disclosure SEC source: 0001637761-23-000013 · wf-form4_167278467472357.xml · nonDerivative · entry 1 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,695 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document
December 28, 2022 Filed Dec 30, 2022 21:28 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	OtherCommon Stock	2,500	$4.92	$12,300.00	Disclosure SEC source: 0001637761-22-000132 · wf-form4_167243569353487.xml · nonDerivative · entry 1 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,333 F1 · kind: These shares were acquired under the issuer's 2015 Employee Stock Purchase Plan (the "ESPP") in a transaction that was exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 1, 2022. Read SEC document
February 28, 2022 Filed Mar 3, 2022 01:38 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	GrantEmployee Stock Option (Right to Buy) · Derivative	21,236	$0.00 Strike: $15.00	$0.00	Disclosure SEC source: 0001637761-22-000046 · wf-form4_164627150297932.xml · derivative · entry 2 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,236 Underlying: Common Stock · 21,236 shares Expires 2030-02-28 F3 · derivative.exercise_date: The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter. Read SEC document
February 28, 2022 Filed Mar 3, 2022 01:38 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	GrantRestricted Stock Units · Derivative	33,977	$0.00	$0.00	Disclosure SEC source: 0001637761-22-000046 · wf-form4_164627150297932.xml · derivative · entry 1 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,977 Underlying: Common Stock · 33,977 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025. F2 · derivative.expiration_date: The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025. Read SEC document
January 28, 2022 Filed Feb 2, 2022 00:17 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionRestricted Stock Units · Derivative	6,484	$0.00	$0.00	Disclosure SEC source: 0001637761-22-000029 · wf-form4_164376104141665.xml · derivative · entry 3 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,970 Underlying: Common Stock · 6,484 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The reporting person was granted 19,454 restricted stock units on January 28, 2021, which vest in three equal installments on each of January 28, 2022, 2023, and 2024. F3 · derivative.expiration_date: The reporting person was granted 19,454 restricted stock units on January 28, 2021, which vest in three equal installments on each of January 28, 2022, 2023, and 2024. Read SEC document
January 28, 2022 Filed Feb 2, 2022 00:17 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Tax withholdingCommon Stock	2,243	$11.39	$25,547.77	Disclosure SEC source: 0001637761-22-000029 · wf-form4_164376104141665.xml · nonDerivative · entry 2 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,833 F2 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units that occurred on January 28, 2022. No shares were sold in connection with this transaction. Read SEC document
January 28, 2022 Filed Feb 2, 2022 00:17 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionCommon Stock	6,484	Not disclosed	Not disclosed	Disclosure SEC source: 0001637761-22-000029 · wf-form4_164376104141665.xml · nonDerivative · entry 1 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,076 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document
January 01, 2022 Filed Jan 5, 2022 02:22 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionRestricted Stock Units · Derivative	8,362	$0.00	$0.00	Disclosure SEC source: 0001637761-22-000012 · wf-form4_164134933856537.xml · derivative · entry 5 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,362 Underlying: Common Stock · 8,362 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F4 · derivative.exercise_date: The reporting person was granted 25,086 restricted stock units on January 1, 2020, which vest in three equal installments on each of January 1, 2021, 2022 and 2023. F4 · derivative.expiration_date: The reporting person was granted 25,086 restricted stock units on January 1, 2020, which vest in three equal installments on each of January 1, 2021, 2022 and 2023. Read SEC document
January 01, 2022 Filed Jan 5, 2022 02:22 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionRestricted Stock Units · Derivative	3,564	$0.00	$0.00	Disclosure SEC source: 0001637761-22-000012 · wf-form4_164134933856537.xml · derivative · entry 4 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,564 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The reporting person was granted 10,691 restricted stock units on January 1, 2019, which vest in three equal installments on each of January 1, 2020, 2021, and 2022. F3 · derivative.expiration_date: The reporting person was granted 10,691 restricted stock units on January 1, 2019, which vest in three equal installments on each of January 1, 2020, 2021, and 2022. Read SEC document
January 01, 2022 Filed Jan 5, 2022 02:22 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Tax withholdingCommon Stock	4,801	$13.62	$65,389.62	Disclosure SEC source: 0001637761-22-000012 · wf-form4_164134933856537.xml · nonDerivative · entry 3 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,592 F2 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units that occurred on January 1, 2022. No shares were sold in connection with this transaction. Read SEC document
January 01, 2022 Filed Jan 5, 2022 02:22 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionCommon Stock	8,362	Not disclosed	Not disclosed	Disclosure SEC source: 0001637761-22-000012 · wf-form4_164134933856537.xml · nonDerivative · entry 2 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,393 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document
January 01, 2022 Filed Jan 5, 2022 02:22 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionCommon Stock	3,564	Not disclosed	Not disclosed	Disclosure SEC source: 0001637761-22-000012 · wf-form4_164134933856537.xml · nonDerivative · entry 1 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,031 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document
June 30, 2021 Filed Jul 2, 2021 23:08 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	OtherCommon Stock	2,383	$8.92	$21,256.36	Disclosure SEC source: 0001637761-21-000152 · wf-form4_162526728122848.xml · nonDerivative · entry 1 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,467 F1 · kind: These shares were acquired under the issuer's 2015 Employee Stock Purchase Plan (the "ESPP") in a transaction that was exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 1, 2020. Read SEC document
January 28, 2021 Filed Jan 29, 2021 22:28 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	GrantEmployee Stock Option (Right to Buy) · Derivative	16,196	$0.00 Strike: $16.86	$0.00	Disclosure SEC source: 0001637761-21-000036 · wf-form4_161195930228468.xml · derivative · entry 2 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,196 Underlying: Common Stock · 16,196 shares Expires 2029-01-28 F3 · derivative.exercise_date: The option vests as to 25% of the underlying shares on January 28, 2022 and the remaining 75% in twelve substantially equal quarterly installments thereafter. Read SEC document
January 28, 2021 Filed Jan 29, 2021 22:28 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	GrantRestricted Stock Units · Derivative	19,454	$0.00	$0.00	Disclosure SEC source: 0001637761-21-000036 · wf-form4_161195930228468.xml · derivative · entry 1 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,454 Underlying: Common Stock · 19,454 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024. F2 · derivative.expiration_date: The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024. Read SEC document
January 01, 2021 Filed Jan 5, 2021 21:14 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionRestricted Stock Units · Derivative	8,362	$0.00	$0.00	Disclosure SEC source: 0001637761-21-000016 · wf-form4_160988122462837.xml · derivative · entry 8 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,724 Underlying: Common Stock · 8,362 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F7 · derivative.exercise_date: The reporting person was granted 25,086 restricted stock units on January 1, 2020, which vest in three equal installments on each of January 1, 2021, 2022 and 2023. F7 · derivative.expiration_date: The reporting person was granted 25,086 restricted stock units on January 1, 2020, which vest in three equal installments on each of January 1, 2021, 2022 and 2023. Read SEC document
January 01, 2021 Filed Jan 5, 2021 21:14 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionRestricted Stock Units · Derivative	3,564	$0.00	$0.00	Disclosure SEC source: 0001637761-21-000016 · wf-form4_160988122462837.xml · derivative · entry 7 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,564 Underlying: Common Stock · 3,564 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F6 · derivative.exercise_date: The reporting person was granted 10,691 restricted stock units on January 1, 2019, which vest in three equal installments on each of January 1, 2020, 2021, and 2022. F6 · derivative.expiration_date: The reporting person was granted 10,691 restricted stock units on January 1, 2019, which vest in three equal installments on each of January 1, 2020, 2021, and 2022. Read SEC document
January 01, 2021 Filed Jan 5, 2021 21:14 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionRestricted Stock Units · Derivative	12,551	$0.00	$0.00	Disclosure SEC source: 0001637761-21-000016 · wf-form4_160988122462837.xml · derivative · entry 6 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,551 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F5 · derivative.exercise_date: The reporting person was granted 37,651 restricted stock units on March 5, 2018, which vest in three equal installments on each of January 1, 2019, 2020 and 2021. F5 · derivative.expiration_date: The reporting person was granted 37,651 restricted stock units on March 5, 2018, which vest in three equal installments on each of January 1, 2019, 2020 and 2021. Read SEC document
January 01, 2021 Filed Jan 5, 2021 21:14 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Tax withholdingCommon Stock	11,349	$17.45	$198,040.05	Disclosure SEC source: 0001637761-21-000016 · wf-form4_160988122462837.xml · nonDerivative · entry 5 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,084 F4 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units that occurred on January 1, 2021. No shares were sold in connection with this transaction. Read SEC document
January 01, 2021 Filed Jan 5, 2021 21:14 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionCommon Stock	8,362	Not disclosed	Not disclosed	Disclosure SEC source: 0001637761-21-000016 · wf-form4_160988122462837.xml · nonDerivative · entry 4 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,433 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document
January 01, 2021 Filed Jan 5, 2021 21:14 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionCommon Stock	3,564	Not disclosed	Not disclosed	Disclosure SEC source: 0001637761-21-000016 · wf-form4_160988122462837.xml · nonDerivative · entry 3 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,071 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document
January 01, 2021 Filed Jan 5, 2021 21:14 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionCommon Stock	12,551	Not disclosed	Not disclosed	Disclosure SEC source: 0001637761-21-000016 · wf-form4_160988122462837.xml · nonDerivative · entry 2 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,507 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document
December 31, 2020 Filed Jan 5, 2021 21:14 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	OtherCommon Stock	1,134	$8.92	$10,115.28	Disclosure SEC source: 0001637761-21-000016 · wf-form4_160988122462837.xml · nonDerivative · entry 1 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,956 F1 · kind: These shares were acquired under the issuer's 2015 Employee Stock Purchase Plan (the "ESPP") in a transaction that was exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 1, 2020. Read SEC document
June 30, 2020 Filed Jul 2, 2020 20:11 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	OtherCommon Stock	1,133	$8.90	$10,083.70	Disclosure SEC source: 0001637761-20-000092 · wf-form4_159372065884188.xml · nonDerivative · entry 1 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,822 F1 · kind: These shares were acquired under the issuer's 2015 Employee Stock Purchase Plan (the "ESPP") in a transaction that was exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2020. Read SEC document
April 23, 2020 Filed Apr 24, 2020 20:23 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	GrantEmployee Stock Option (Right to Buy) · Derivative	6,089	$0.00 Strike: $9.93	$0.00	Disclosure SEC source: 0001637761-20-000043 · wf-form4_158775980451088.xml · derivative · entry 1 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,089 Underlying: Common Stock · 6,089 shares Expires 2028-04-23 F1 · derivative.exercise_date: The option will fully vest and become exercisable on June 21, 2020, subject to the Reporting Person's continued service to the issuer. Read SEC document
January 01, 2020 Filed Jan 3, 2020 02:17 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	GrantEmployee Stock Option (Right to Buy) · Derivative	27,873	$0.00 Strike: $12.01	$0.00	Disclosure SEC source: 0001637761-20-000011 · wf-form4_157801784966638.xml · derivative · entry 10 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,873 Underlying: Common Stock · 27,873 shares Expires 2028-01-01 F9 · derivative.exercise_date: The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter. Read SEC document
January 01, 2020 Filed Jan 3, 2020 02:17 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	GrantRestricted Stock Units · Derivative	25,086	$0.00	$0.00	Disclosure SEC source: 0001637761-20-000011 · wf-form4_157801784966638.xml · derivative · entry 9 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,086 Underlying: Common Stock · 25,086 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F8 · derivative.exercise_date: The restricted stock units vest in three equal installments on each of January 1, 2021, 2022 and 2023. F8 · derivative.expiration_date: The restricted stock units vest in three equal installments on each of January 1, 2021, 2022 and 2023. Read SEC document
January 01, 2020 Filed Jan 3, 2020 02:17 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionRestricted Stock Units · Derivative	3,563	$0.00	$0.00	Disclosure SEC source: 0001637761-20-000011 · wf-form4_157801784966638.xml · derivative · entry 8 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,128 Underlying: Common Stock · 3,563 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F7 · derivative.exercise_date: The reporting person was granted 10,691 restricted stock units on January 1, 2019, which vest in three equal installments on each of January 1, 2020, 2021, and 2022. F7 · derivative.expiration_date: The reporting person was granted 10,691 restricted stock units on January 1, 2019, which vest in three equal installments on each of January 1, 2020, 2021, and 2022. Read SEC document
January 01, 2020 Filed Jan 3, 2020 02:17 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionRestricted Stock Units · Derivative	12,550	$0.00	$0.00	Disclosure SEC source: 0001637761-20-000011 · wf-form4_157801784966638.xml · derivative · entry 7 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,551 Underlying: Common Stock · 12,550 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F6 · derivative.exercise_date: The reporting person was granted 37,651 restricted stock units on March 5, 2018, which vest in three equal installments on each of January 1, 2019, 2020 and 2021. F6 · derivative.expiration_date: The reporting person was granted 37,651 restricted stock units on March 5, 2018, which vest in three equal installments on each of January 1, 2019, 2020 and 2021. Read SEC document
January 01, 2020 Filed Jan 3, 2020 02:17 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionRestricted Stock Units · Derivative	15,574	$0.00	$0.00	Disclosure SEC source: 0001637761-20-000011 · wf-form4_157801784966638.xml · derivative · entry 6 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,574 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F5 · derivative.exercise_date: The reporting person was granted 46,720 restricted stock units on February 7, 2017, which vest in three equal installments on each of January 1, 2018, 2019 and 2020. F5 · derivative.expiration_date: The reporting person was granted 46,720 restricted stock units on February 7, 2017, which vest in three equal installments on each of January 1, 2018, 2019 and 2020. Read SEC document
January 01, 2020 Filed Jan 3, 2020 02:17 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Tax withholdingCommon Stock	11,623	$12.01	$139,592.23	Disclosure SEC source: 0001637761-20-000011 · wf-form4_157801784966638.xml · nonDerivative · entry 5 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,689 F4 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units that occurred on January 1, 2020. No shares were sold in connection with this transaction. Read SEC document
January 01, 2020 Filed Jan 3, 2020 02:17 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionCommon Stock	3,563	Not disclosed	Not disclosed	Disclosure SEC source: 0001637761-20-000011 · wf-form4_157801784966638.xml · nonDerivative · entry 4 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document
January 01, 2020 Filed Jan 3, 2020 02:17 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionCommon Stock	12,550	Not disclosed	Not disclosed	Disclosure SEC source: 0001637761-20-000011 · wf-form4_157801784966638.xml · nonDerivative · entry 3 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,749 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document
January 01, 2020 Filed Jan 3, 2020 02:17 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionCommon Stock	15,574	Not disclosed	Not disclosed	Disclosure SEC source: 0001637761-20-000011 · wf-form4_157801784966638.xml · nonDerivative · entry 2 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document
December 31, 2019 Filed Jan 3, 2020 02:17 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	OtherCommon Stock	958	$10.21	$9,781.18	Disclosure SEC source: 0001637761-20-000011 · wf-form4_157801784966638.xml · nonDerivative · entry 1 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,625 F1 · kind: These shares were acquired under the issuer's 2015 Employee Stock Purchase Plan (the "ESPP") in a transaction that was exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on December 31, 2019. Read SEC document
June 28, 2019 Filed Jul 2, 2019 20:34 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	OtherCommon Stock	729	$11.26	$8,210.36	Disclosure SEC source: 0001637761-19-000088 · wf-form4_156209964902666.xml · nonDerivative · entry 1 Lipschultz Tyler · CIK 0001509284 · SVP, Orthobiologics and BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,667 F1 · kind: These shares were acquired under the issuer's 2015 Employee Stock Purchase Plan (the "ESPP") in a transaction that was exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 28, 2019. F3 · balance_after: On the Form 4 filed by the reporting person on January 3, 2019, the amount of shares acquired by the reporting person in the transaction reported in that Form 4 related to the acquisition of shares under the ESPP, and the amount of securities beneficially owned by the reporting person following such acquisition, were both overstated by 35. The amount reported in this Column 5 reflects a reduction of 35 shares to correct this error. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.